Financials
- Market Capitalization 22 M
- Employee 115
- Founded 1998
- CEO N/A
- Website www.celularity.com
- Headquarter Delaware, United States
- FIGI BBG00P2RTT34
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.31
ratio cours/chiffre d'affaires
1.07
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4551 | NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.73 USD | 0.00% | +7.35% | +5.80% | -64.73% | 23.77 M USD | ||
| 4553 | VYNE VYNE Therapeutics Inc. - Common Stock | 0.71 USD | +7.58% | +9.23% | +16.39% | -46.21% | 23.68 M USD | ||
| 4586 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.47 USD | -0.88% | +2.75% | -5.80% | +130.26% | 21.81 M USD | ||
| 4587 | SKYE Skye Bioscience, Inc. - Common Stock | 0.62 USD | -6.06% | -11.43% | -11.43% | -22.50% | 21.79 M USD |